Kore Private Wealth LLC Verastem, Inc. Transaction History

Kore Private Wealth LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$1.69 - $4.2 $5,070 - $12,600	-3,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.86 - $1.44 $2,580 - $4,320	3,000 New	3,000 $4,000
Q2 2019 Aug 14, 2019	SELL	$1.25 - $3.14 $3,750 - $9,420	-3,000 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$2.79 - $4.09 $2,790 - $4,090	1,000 Added 50.0%	3,000 $9,000
Q4 2018 May 23, 2019	BUY	$3.23 - $7.01 $6,460 - $14,020	2,000 New	2,000 $7,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.25B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Kore Private Wealth LLC with notifications on news.